The DOI matches its Crossref record, with a small difference in title or year; 46 of the 46 references it cites were found in a registry or an index.
The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.
Open accessAbstract
OBJECTIVE: The Diabetes Prevention Program (DPP) is a 27-center randomized clinical trial designed to evaluate the safety and efficacy of interventions that may delay or prevent development of diabetes in people at increased risk for type 2 diabetes. RESEARCH DESIGN AND METHODS: Eligibility requirements were age > or = 25 years, BMI > or = 24 kg/m2 (> or = 22 kg/m2 for Asian-Americans), and impaired glucose tolerance plus a fasting plasma glucose of 5.3-6.9 mmol/l (or < or = 6.9 mmol for American Indians). Randomization of participants into the DPP over 2.7 years ended in June 1999. Baseline data for the three treatment groups--intensive lifestyle modification, standard care plus metformin, and standard care plus placebo--are presented for the 3,234 participants who have been randomized. RESULTS: Of all participants, 55% were Caucasian, 20% were African-American, 16% were Hispanic, 5% were American Indian, and 4% were Asian-American. Their average age at entry was 51 +/- 10.7 years (mean +/- SD), and 67.7% were women. Moreover, 16% were < 40 years of age, and 20% were > or = 60 years of age. Of the women, 48% were postmenopausal. Men and women had similar frequencies of history of hypercholesterolemia (37 and 33%, respectively) or hypertension (29 and 26%, respectively). On the basis of fasting lipid determinations, 54% of men and 40% of women fit National Cholesterol Education Program criteria for abnormal lipid profiles. More men than women were current or former cigarette smokers or had a history of coronary heart disease. Furthermore, 66% of men and 71% of women had a first-degree relative with diabetes. Overall, BMI averaged 34.0 +/- 6.7 kg/m2 at baseline with 57% of the men and 73% of women having a BMI > or = 30 kg/m2. Average fasting plasma glucose (6.0 +/- 0.5 mmol/l) and HbA1c (5.9 +/- 0.5%) in men were comparable with values in women (5.9 +/- 0.4 mmol/l and 5.9 +/- 0.5%, respectively). CONCLUSIONS: The DPP has successfully randomized a large cohort of participants with a wide distribution of age, obesity, and ethnic and racial backgrounds who are at high risk for developing type 2 diabetes. The study will examine the effects of interventions on the development of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dysglycemia is strongly associated with the development of overweight status or obesity, as most DM2 patients are overweight or obese (44–46).”
From GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin (2020) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Kumar, M. V. J., & Chippada, A. R. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,171
Eriksson, K. F., & Lindg�rde, F. (1991) · Diabetologia · doi:10.1007/bf00400196 · Cited by 1,092
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Statistical Considerations in the Intent-to-Treat Principle
Lachin, J. M. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00046-5 · Cited by 652
Edelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffher, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.701 · Cited by 641
Research works printed but not linked: 1
- [32]32. Hainline A Jr, Karon J, Lippel K (Eds.): Manual of Laboratory Operations. 2nd ed. Lipid Research Clinics Program, Lipid and Lipoprotein Analysis, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health (updated 1983)
Cited by
Sorted by citations
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
The Diabetes Prevention Program (DPP)
The Diabetes Prevention Program (DPP) Research Group (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2165 · Cited by 1,938
Effect of weight loss with lifestyle intervention on risk of diabetes
Hamman, R. F., Wing, R. R., Edelstein, S. L., Lachin, J. M., Bray, G. A., Delahanty, L., Hoskin, M., Kriska, A. M., Mayer-Davis, E. J., Pi-Sunyer, X., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0560 · Cited by 1,344
Gillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K. (2007) · BMJ · doi:10.1136/bmj.39063.689375.55 · Cited by 1,171
Ratner, R. E., Christophi, C. A., Metzger, B. E., Dabelea, D., Bennett, P. H., Pi-Sunyer, X., Fowler, S., Kahn, S. E., & The Diabetes Prevention Program Research Group (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0772 · Cited by 867
Statistical Considerations in the Intent-to-Treat Principle
Lachin, J. M. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00046-5 · Cited by 652
Herman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574
The Diabetes Prevention Program Research Group (2005) · Diabetes Care · doi:10.2337/diacare.28.4.888 · Cited by 572
Multiple risk factor interventions for primary prevention of coronary heart disease
Ebrahim, S. B. J., Taylor, F. C., Ward, K. J., Beswick, A. D., Burke, M., & Smith, G. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001561.pub3 · Cited by 558
Yanovski, S. Z., & Yanovski, J. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012586 · Cited by 555
Perreault, L., Pan, Q., Mather, K. J., Watson, K. E., Hamman, R. F., & Kahn, S. E. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60525-x · Cited by 532
The Prevention or Delay of Type 2 Diabetes
American Diabetes Association, & National Institute of Diabetes, D. A. K. D. (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s62 · Cited by 520
BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening
Hsu, W. C., Araneta, M. R. G., Kanaya, A. M., Chiang, J. L., & Fujimoto, W. (2015) · Diabetes Care · doi:10.2337/dc14-2391 · Cited by 500
The Diabetes Prevention Program Research Group (2012) · Diabetes Care · doi:10.2337/dc11-1299 · Cited by 494
The Prevention or Delay of Type 2 Diabetes
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.4.742 · Cited by 493
Prevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program
The Diabetes Prevention Program Research Group* (2005) · Diabetes · doi:10.2337/diabetes.54.4.1150 · Cited by 474
A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes
Paulweber, B., Valensi, P. E., Lindström, J., Lalic, N. M., Greaves, C. J., McKee, M., Kissimova‐Skarbek, K., Liatis, S., Cosson, E., Szendroedi, J., et al. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1240928 · Cited by 485
The Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.8.2404 · Cited by 446
Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus
Norris, S. L., Zhang, X., Avenell, A., Gregg, E. W., Brown, T. J., Schmid, C. H., & Lau, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004095.pub2 · Cited by 372
Exercise or exercise and diet for preventing type 2 diabetes mellitus
Orozco, L. J., Buchleitner, A. M., Giménez‐Pérez, G., Figuls, M. R. I., Richter, B., & Mauricio, D. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003054.pub3 · Cited by 346
Weight loss during the intensive intervention phase of the weight-loss maintenance trial
Hollis, J. F., Gullion, C. M., Stevens, V. J., Brantley, P. J., Appel, L. J., Ard, J. D., Champagne, C. M., Dalcin, A., Erlinger, T. P., Funk, K., et al. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.04.013 · Cited by 321
Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes
Eddy, D. M., Schlessinger, L., & Kahn, R. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-4-200508160-00006 · Cited by 318
Hemmingsen, B., Gimenez-Perez, G., Mauricio, D., Roqué i Figuls, M., Metzendorf, M.-I., & Richter, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003054.pub4 · Cited by 316
Glasgow, R. E., Magid, D. J., Beck, A., Ritzwoller, D., & Estabrooks, P. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000163645.41407.09 · Cited by 308
Weight Loss of Black, White, and Hispanic Men and Women in the Diabetes Prevention Program
West, D. S., Prewitt, T. E., Bursac, Z., & Felix, H. C. (2008) · Obesity · doi:10.1038/oby.2008.224 · Cited by 306
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
Gottwald‐Hostalek, U., Gwilt, M., & Hildemann, S. K. (2015) · Drugs · doi:10.1007/s40265-015-0416-8 · Cited by 283
The prevention of type 2 diabetes
F. T. D. P. P. R. G., Crandall, J. P., Knowler, W. C., Kahn, S. E., Marrero, D., Florez, J. C., Bray, G. A., Haffner, S. M., Hoskin, M., & Nathan, D. M. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0843 · Cited by 261
Bray, G. A., Jablonski, K. A., Fujimoto, W. Y., Barrett-Connor, E. L., Haffner, S. M., Hanson, R. L., Hill, J. O., Hubbard, V. S., Kriska, A. M., Stamm, E. R., et al. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1212 · Cited by 258
Rubin, R. R., Ma, Y., Marrero, D. G., Peyrot, M., Barrett-Connor, E. L., Kahn, S. E., Haffner, S. M., Price, D. W., Knowler, W. C., & for the Diabetes Prevention Program Research Group (2008) · Diabetes Care · doi:10.2337/dc07-1827 · Cited by 242
Prevention or Delay of Type 2 Diabetes
Sherwin, R. S., Anderson, R. M., Buse, J. B., Chin, M. H., Eddy, D. M., FRADKIN, J. E., Ganiats, T. G., Ginsberg, H. N., Kahn, R., Nwankwo, R. B., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s47 · Cited by 244
Changes in incidence of diabetes in U.S. adults, 1997–2003
Geiss, L. S., Pan, L., Cadwell, B., Gregg, E. W., Benjamin, S. M., & Engelgau, M. M. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.12.009 · Cited by 229
Norris, S. L., Kansagara, D. L., Bougatsos, C., & Fu, R. F. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00008 · Cited by 226
Carnethon, M. R., Prineas, R. J., Temprosa, M., Zhang, Z.-M., Uwaifo, G., Molitch, M. E., & for the Diabetes Prevention Program Research Group (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1729 · Cited by 220
Joiner, K. L., Nam, S., & Whittemore, R. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.04.033 · Cited by 223
Kadowaki, T., Sekikawa, A. M., Murata, K., Maegawa, H., Takamiya, T., Okamura, T., El‐Saed, A., Miyamatsu, N., Edmundowicz, D., Kita, Y., et al. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803248 · Cited by 216
Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis
Glechner, A., Keuchel, L., Affengruber, L., Titscher, V., Sommer, I., Matyas, N., Wagner, G., Kien, C., Klerings, I., & Gartlehner, G. (2018) · Primary care diabetes · doi:10.1016/j.pcd.2018.07.003 · Cited by 224
Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program
Perreault, L., Kahn, S. E., Christophi, C. A., Knowler, W. C., Hamman, R. F., & the Diabetes Prevention Program Research Group (2009) · Diabetes Care · doi:10.2337/dc09-0523 · Cited by 209
Golay, A. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803695 · Cited by 206
Marshall, M. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.028274 · Cited by 215
Gorin, A. A., Wing, R. R., Fava, J. L., Jakicic, J. M., Jeffery, R. W., West, D. S., Brelje, K., & DiLillo, V. G. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.150 · Cited by 205
Prevention of type 2 diabetes: A review
Hussain, A., Claussen, B., Ramachandran, A., & Williams, R. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.09.020 · Cited by 201
Knowler (2011) · doi:10.1001/archinternmed.2011.367 · Cited by 194
Hivert, M.-F., Jablonski, K. A., Perreault, L., Saxena, R., McAteer, J. B., Franks, P. W., Hamman, R. F., Kahn, S. E., Haffner, S., the DIAGRAM Consortium, et al. (2011) · Diabetes · doi:10.2337/db10-1119 · Cited by 191
Estimated Number of Adults With Prediabetes in the U.S. in 2000
Benjamin, S. M., Valdez, R. A., Geiss, L. S., Rolka, D. B., & Narayan, K. M. V. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.645 · Cited by 191
Impact of 3‐year lifestyle intervention on postprandial glucose metabolism: the SLIM study
Roumen, C., Corpeleijn, E., Feskens, E. J. M., Mensink, M., Saris, W. H. M., & Blaak, E. E. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02417.x · Cited by 187
Psychological and Behavioral Correlates of Baseline BMI in the Diabetes Prevention Program (DPP)
Delahanty, L. M., Meigs, J. B., Hayden, D. L., Williamson, D. A., & Nathan, D. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.1992 · Cited by 189
The Rise of `Recruitmentology'
Epstein, S. (2008) · Social Studies of Science · doi:10.1177/0306312708091930 · Cited by 186
The Diabetes Prevention Program
The DPP Research Group (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00184-2 · Cited by 175
Effect of macronutrient intake on the development of glucose intolerance during pregnancy
Saldana, T. M., Siega‐Riz, A. M., & Adair, L. S. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.3.479 · Cited by 167
Long-term non-pharmacological weight loss interventions for adults with prediabetes
Norris, S. L., Zhang, X., Avenell, A., Gregg, E., Schmid, C. H., & Lau, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005270 · Cited by 60
Health-Related Quality of Life in Older Adults at Risk for Disability
Groessl, E. J., Kaplan, R. M., Rejeski, W. J., Katula, J. A., King, A. C., Frierson, G. M., Glynn, N. W., Hsu, F., Walkup, M. P., & Pahor, M. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.04.031 · Cited by 177
Psychological predictors of physical activity in the Diabetes Prevention Program
Delahanty, L. M., Conroy, M. B., & Nathan, D. M. (2006) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2006.02.011 · Cited by 165
Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program
Mather, K. J., Funahashi, T., Matsuzawa, Y., Edelstein, S. L., Bray, G. A., Kahn, S. E., Crandall, J. P., Marcovina, S. M., Goldstein, B., Goldberg, R. B., et al. (2008) · Diabetes · doi:10.2337/db07-1419 · Cited by 161
Prevalence, predisposition and prevention of type II diabetes
Cheng, D. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-29 · Cited by 164
Bray, G. A. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.031 · Cited by 158
Apolzan, J. W., Venditti, E. M., Edelstein, S. L., Knowler, W. C., Dabelea, D., Boyko, E. J., Pi-Sunyer, X., Kalyani, R. R., Franks, P. W., Srikanthan, P., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m18-1605 · Cited by 156
Posttransplant Metabolic Syndrome
Pagadala, M. R., Dasarathy, S., Eghtesad, B., & McCullough, A. J. (2009) · Liver Transplantation · doi:10.1002/lt.21952 · Cited by 155
Baker, M. K., Simpson, K. A., Lloyd, B. D., Bauman, A. E., & Singh, M. A. F. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.06.030 · Cited by 159
Guigas, B., Détaille, D., Chauvin, C., Batandier, C., Oliveira, F. D., Fontaine, E. M., & Leverve, X. M. (2004) · Biochemical Journal · doi:10.1042/bj20040885 · Cited by 153
Rasouli, N., Raue, U., Miles, L. M., Lu, T., Gregorio, G. B. D., Elbein, S. C., & Kern, P. A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00522.2004 · Cited by 149
Interventions to improve adherence to lipid lowering medication
Schedlbauer, A., Davies, P. A., & Fahey, T. P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004371.pub3 · Cited by 152
Factors influencing the ability to self-manage diabetes for adults living with type 1 or 2 diabetes
Wilkinson, A., Whitehead, L., & Ritchie, L. (2014) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2013.01.006 · Cited by 140
Cárdenas, A., Gold, D. R., Hauser, R. B., Kleinman, K., Hivert, M., Calafat, A. M., Ye, X., Webster, T. F., Horton, E. S., & Oken, E. (2017) · Environmental Health Perspectives · doi:10.1289/ehp1612 · Cited by 145
Long-term effectiveness of weight-loss interventions in adults with pre-diabetes
Norris, S. L., Zhang, X., Avenell, A., Gregg, E. W., Bowman, B. A., Schmid, C. H., & Lau, J. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.08.006 · Cited by 147
Chiasson, J. L., & RABASA-LHORET, R. P. R. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s34 · Cited by 148
Li, Z., Hong, K. M., Saltsman, P., DeShields, S., Bellman, M., Thames, G., Liu, Y., Wang, H., Elashoff, R. M., & Heber, D. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602089 · Cited by 143
Statin use and risk of developing diabetes: results from the Diabetes Prevention Program
Crandall, J. P., Mather, K., Rajpathak, S. N., Goldberg, R. B., Watson, K., Foo, S., Ratner, R., Barrett-Connor, E., & Temprosa, M. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000438 · Cited by 137
An Update on The Diabetes Prevention Program
Ratner, R. E. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.20 · Cited by 141
Diabetes Prevention Program Research Group (2015) · Diabetes Care · doi:10.2337/dc14-0886 · Cited by 139
Florez, J. C., Jablonski, K. A., Sun, M. W., Bayley, N., Kahn, S. E., Shamoon, H., Hamman, R. F., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2275 · Cited by 131
Perreault, L., Temprosa, M., Mather, K. J., Horton, E., Kitabchi, A., Larkin, M., Montez, M. G., Thayer, D., Orchard, T. J., Hamman, R. F., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0656 · Cited by 131
Perreault, L., Ma, Y., Dagogo-Jack, S. E., Horton, E. S., Marrero, D. G., Crandall, J. P., Barrett-Connor, E. L., & Program, F. T. D. P. (2008) · Diabetes Care · doi:10.2337/dc07-2390 · Cited by 132
Yoon, U., Kwok, L. L., & Magkidis, A. (2012) · Metabolism · doi:10.1016/j.metabol.2012.07.009 · Cited by 132
Walford, G. A., Ma, Y., Clish, C. B., Florez, J. C., Wang, T. J., & Gerszten, R. E. (2016) · Diabetes · doi:10.2337/db15-1063 · Cited by 128
Prevention of Type 2 Diabetes in Women With Previous Gestational Diabetes
Ratner, R. E. (2007) · Diabetes Care · doi:10.2337/dc07-s223 · Cited by 125
West, D. S., Gorin, A. A., Subak, L. L., Foster, G. D., Bragg, C., Hecht, J., Schembri, M. E., & Wing, R. R. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.138 · Cited by 125
Eriksson, M. K., Franks, P. W., & Eliasson, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005195 · Cited by 123
The Cost of Diabetes Type II in Europe The CODE-2 Study
Massi‐Benedetti, M. (2002) · Diabetologia · doi:10.1007/s00125-002-0860-3 · Cited by 123
Florez, J. C., Jablonski, K. A., Kahn, S. E., Franks, P. W., Dabelea, D., Hamman, R. F., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2007) · Diabetes · doi:10.2337/db06-0966 · Cited by 119
Body Size and Shape Changes and the Risk of Diabetes in the Diabetes Prevention Program
Fujimoto, W. Y., Jablonski, K. A., Bray, G. A., Kriska, A. M., Barrett-Connor, E. L., Haffner, S. M., Hanson, R. L., Hill, J. O., Hubbard, V. S., Stamm, E. R., et al. (2007) · Diabetes · doi:10.2337/db07-0009 · Cited by 117
Mier, N., Ory, M. G., & Medina, A. A. (2009) · Health Promotion Practice · doi:10.1177/1524839908328991 · Cited by 115
Escalona, A., Pimentel, F., Sharp, A. C., Becerra, P., M, M. S., Turiel, D., Muñoz, R., Claudia Bambs, S., Guzmán, S., Ibañez, L. A., et al. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31825498c4 · Cited by 111
The Reality of Type 2 Diabetes Prevention
Kahn, R., & Davidson, M. B. (2014) · Diabetes Care · doi:10.2337/dc13-1954 · Cited by 117
Multiple risk factor interventions for primary prevention of coronary heart disease
Ebrahim, S. B. J., Beswick, A. D., Burke, M., & Smith, G. D. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001561.pub2 · Cited by 107
Li, W., Procter-Gray, E., Churchill, L., Crouter, S. E., Kane, K., Tian, J., Franklin, P. D., Ockene, J. K., & Gurwitz, J. H. (2017) · Care weekly · doi:10.14283/cw.2017.4 · Cited by 105
Fogelholm, M., Larsen, T. M., Westerterp‐Plantenga, M. S., Macdonald, I. A., Martínez, J. A., Boyadjieva, N. I., Poppitt, S. D., Schlicht, W. M., Stratton, G., Sundvall, J., et al. (2017) · Nutrients · doi:10.3390/nu9060632 · Cited by 109
Florez, H. J., Pan, Q., Ackermann, R. T., Marrero, D. G., Barrett-Connor, E. L., Delahanty, L. M., Kriska, A. M., Saudek, C. D., Goldberg, R. B., & Rubin, R. R. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2122-5 · Cited by 99
Prevention of Type 2 diabetes mellitus. A review of the evidence and its application in a UK setting
Davies, M. J., Tringham, J. R., Troughton, J., & Khunti, K. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01176.x · Cited by 94
The development and description of the comparison group in the Look AHEAD trial
The Look AHEAD Research Group (2011) · Clinical Trials · doi:10.1177/1740774511405858 · Cited by 95
Joshi, S. (2016) · Annals of Global Health · doi:10.1016/j.aogh.2016.01.002 · Cited by 94
Physical Activity in Individuals at Risk for Diabetes
Kriska, A. M., Edelstein, S. L., Hamman, R. F., Otto, A. D., Bray, G. A., Mayer‐Davis, E. J., Wing, R. R., Horton, E. S., Haffner, S. M., & Regensteiner, J. G. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000218138.91812.f9 · Cited by 93
Dietary intake in the Diabetes Prevention Program cohort: baseline and 1-year post-randomization
Mayer‐Davis, E. J., Sparks, K. C., Km, H., Costacou, T., Lovejoy, J. C., Regensteiner, J. G., Hoskin, M. A., Kriska, A. M., & Bray, G. A. (2004) · Annals of Epidemiology · doi:10.1016/j.annepidem.2004.02.004 · Cited by 91
Actos Now for the prevention of diabetes (ACT NOW) study
DeFronzo, R. A., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S., Henry, R. R., Kitabchi, A. E., Mudaliar, S., Musi, N., Ratner, R., et al. (2009) · BMC Endocrine Disorders · doi:10.1186/1472-6823-9-17 · Cited by 89
Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Adiposity
Cárdenas, A., Hauser, R. B., Gold, D. R., Kleinman, K., Hivert, M., Fleisch, A. F., Lin, P. D., Calafat, A. M., Webster, T. F., Horton, E. S., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1493 · Cited by 95
Changes in Health State Utilities With Changes in Body Mass in the Diabetes Prevention Program
Ackermann, R. T., Edelstein, S. L., Narayan, K. M. V., Zhang, P., Engelgau, M. M., Herman, W. H., & Marrero, D. G. (2009) · Obesity · doi:10.1038/oby.2009.114 · Cited by 88
Trickett, E. J. (2011) · American Journal of Public Health · doi:10.2105/ajph.2011.300124 · Cited by 89
Nesbitt, G. S., Smye, M. G., Sheridan, B., Lappin, T. R. J., & Trimble, E. R. (2006) · Clinical Trials · doi:10.1177/1740774506070695 · Cited by 87
Biomarkers of body iron stores and risk of developing type 2 diabetes
Rajpathak, S. N., Wylie‐Rosett, J., Gunter, M. J., Negassa, A., Kabat, G. C., Rohan, T. E., & Crandall, J. P. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00985.x · Cited by 85
Liquid Meal Replacements and Glycemic Control in Obese Type 2 Diabetes Patients
Yip, I., Go, V. L. W., DeShields, S., Saltsman, P., Bellman, M., Thames, G., Murray, S. P. L., Wang, H., Elashoff, R. M., & Heber, D. (2001) · Obesity Research · doi:10.1038/oby.2001.140 · Cited by 86
Metadata
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2000-11-01
- Volume
- 23
- Issue
- 11
- Pages
- 1619-1629
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC1360735
- OpenAlex
- W1935237410
- Cited by
- 399
- References
- 44
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 19 · 2023: 8 · 2022: 6 · 2021: 10 · 2020: 12 · 2019: 11 · 2018: 10 · 2017: 18 · 2016: 16 · 2015: 16 · 2014: 17 · 2013: 17 · 2012: 22
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Diabetes Association
- Bristol-Myers Squibb
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Institute on Aging
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK048489)
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes prevention, impaired glucose tolerance, prediabetes, metformin, lifestyle modification, baseline characteristics, sex differences, racial and ethnic differences, body mass index, fasting blood glucose, HbA1c, hypercholesterolemia, hypertension, smoking, coronary artery disease, Diabetes Prevention Program
- MeSH terms
- Adult, Asian, Black or African American, Blood Glucose, Blood Pressure, Cholesterol, Coronary Disease, Diabetes Mellitus, Type 2, Female, Hispanic or Latino, Humans, Hypercholesterolemia, Indians, North American, Lipids, Male, Middle Aged, Patient Education as Topic, Risk Factors, Sex Factors, Smoking, Socioeconomic Factors, United States, Cohort Studies, Body Mass Index, Glucose Intolerance, White People, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review